Industry Partners

---

Rehabilitation and prosthetic technology have advanced enormously, but strength and conditioning following limb loss can still require equipment and exercises originally designed around intact limbs.

LimbAxis is being developed specifically around this challenge.

Its intended role is complementary to prosthetic care - supporting progressive strengthening from rehabilitation and prosthetic readiness through to established prosthetic use and long-term physical conditioning.

For organisations already supporting people with limb loss, LimbAxis represents an opportunity to explore another part of that journey.

LimbAxis is being developed as the Motion Series: four applications covering upper and lower-limb loss both above and below the joint.

Motion T — Transtibial / below-knee
Motion F — Transfemoral / above-knee
Motion R — Transradial / below-elbow
Motion H — Transhumeral / above-elbow

This platform approach creates the potential to address residual limb strengthening across a broader limb-loss population rather than focusing on a single level of amputation.

LimbAxis has already moved beyond the initial idea.

Physical prototype development and early evaluation have enabled feedback from amputees, physiotherapists, prosthetists and rehabilitation professionals to begin informing the next stage of the technology.

The focus now is on further prototype development, structured evaluation and building the evidence required to support future clinical, regulatory and commercial decisions.

LimbAxis remains early-stage, but the direction is clear: develop carefully, test properly and allow evidence to determine what comes next.

Intellectual property has been considered as part of LimbAxis from the outset.

The technology is patent pending, with the patent application submitted and managed by Bryers Intellectual Property Ltd.

Detailed technical information is therefore shared selectively with appropriate parties as commercial and development discussions progress.

LimbAxis Systems is building relationships with organisations and specialists who share an interest in advancing rehabilitation and strength development following limb loss.

Potential areas for collaboration include:

Clinical Evaluation
Working with clinicians and users to support structured evaluation and inform future development.

Research
Collaborating with academic and clinical partners to build evidence around residual limb strengthening and the application of LimbAxis technology.

Product Development
Working with technical partners to advance the Motion Series towards trial-ready prototypes.

Clinical & Regulatory Insight
Drawing on specialist expertise to help shape future clinical and regulatory development.

Industry Collaboration
Exploring opportunities with established rehabilitation, prosthetics and MedTech organisations.

Strategic Licensing
Building relationships with organisations with the expertise, infrastructure and reach to bring LimbAxis technology to wider markets.

LimbAxis combines lived experience of limb loss with an engineering-led approach and growing input from rehabilitation professionals and users.

The technology is not being developed to replace or compete with prosthetics. It addresses an adjacent challenge: enabling progressive residual limb strengthening throughout rehabilitation and into long-term strength and conditioning.

For organisations already operating across prosthetics, rehabilitation and mobility, LimbAxis represents the potential to extend their existing offering into an underserved area of the limb-loss journey.

With patent-pending technology spanning both upper and lower-limb applications, the Motion Series is being developed with future strategic licensing in mind.